
Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma
Author(s) -
Hong-lin Peng,
Kai-Yun You,
Rong Zhang,
Shaoyan Xi,
Tian Zhang,
Jian Dong,
Mengli Cai,
Chengtao Wang,
Huizhong Zhang,
Tongchong Zhou,
Yuanhong Gao,
Bo Wen
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.9125
Subject(s) - medicine , proportional hazards model , immunohistochemistry , colorectal cancer , neoadjuvant therapy , chemoradiotherapy , real time polymerase chain reaction , adenocarcinoma , oncology , pathology , cancer , biology , gene , biochemistry , breast cancer
To investigate predictive value of APAF-1 and COX-2 expression in pathologic complete response (pCR) for patients with rectal adenocarcinoma (RAC) who were treated with neoadjuvant chemoradiotherapy (neo-CRT) followed by total mesorectal excision (TME).